Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Aponia Laboratories is a specialized pharmaceutical company developing topical prescription and over-the-counter pain relief products based on ibuprofen for the NSAID segment of the arthritis pain market. Its products have completed formulation development and non-clinical studies and are undergoing FDA-guided clinical trials.
0 investors
0 investors
0 investors
Applied Biological Laboratories develops antiviral biotechnology treatments targeting respiratory viruses using a patented biologic platform that combines host-directed immune modulation and microbe-directed mechanisms. The company conducts research using human respiratory organoids to identify and develop antiviral and anti-inflammatory therapeutic solutions.
0 investors
0 investors
0 investors
0 investors
AptamiR Therapeutics is a US biotechnology company in pre-clinical development of microRNA-based oligonucleotide therapeutics (antagomirs), including miR-22-3p drug candidates for cardiometabolic disorders such as obesity, diabetes and fatty liver disease (MAFLD/MASH) and candidates for epithelial ovarian cancer. Its approach modulates multiple target genes simultaneously to address complex metabolic diseases and cancer.
0 investors
0 investors
0 investors
Araceli Biosciences builds High Content Imaging platforms and software that provide real-time image analysis and analysis-ready data for therapeutic and drug discovery research. Its tools serve researchers screening compounds, pairing imaging hardware with AI-driven analysis to speed candidate selection in the drug discovery pipeline.
0 investors
0 investors
0 investors
0 investors
0 investors